Skill Guide

Post-market surveillance, adverse event reporting, and performance drift monitoring

The systematic, ongoing collection and analysis of real-world data on medical devices after regulatory clearance to detect safety signals, report mandated adverse events, and identify performance degradation against design specifications.

This skill is critical for maintaining regulatory compliance (e.g., EU MDR, FDA 21 CFR 803) and mitigating legal liability, directly preventing costly recalls and protecting the brand's market authorization. Effective execution transforms safety data into a competitive advantage by enabling proactive product improvements and strengthening trust with clinicians and notified bodies.

1 Careers

1 Categories

9.1 Avg Demand

15% Avg AI Risk

How to Learn Post-market surveillance, adverse event reporting, and performance drift monitoring

Focus on: 1) Mastering regulatory definitions (e.g., serious injury, malfunction) and reporting timelines for MDR/FDA. 2) Understanding core data sources: Complaint Handling Systems, Medical Device Reports (MDRs), and Post-Market Clinical Follow-up (PMCF) plans. 3) Learning to trace a complaint from intake to its classification within a Quality Management System (QMS).

Focus on executing Post-Market Surveillance (PMS) plans, performing trend analysis on complaint data, and drafting Periodic Safety Update Reports (PSURs/PMSRs). Move from data collection to signal detection. Common mistake: failing to distinguish between a singular complaint and a statistically significant trend that triggers a CAPA.

Mastery involves designing integrated surveillance systems that feed directly into risk management files, leading cross-functional teams (R&D, Clinical, Regulatory) to respond to performance drift, and representing the company in regulatory audits. Strategic alignment means leveraging PMS data to inform next-generation product design and preempt market issues.

Practice Projects

Beginner

Case Study/Exercise

MDR Triage and Reporting Simulation

Scenario

A batch of 100 complaints for a Class II implantable insulin pump arrives in the complaint system. One report indicates a serious injury due to over-delivery of insulin. Several others mention inconsistent glucose readings.

How to Execute

1) Apply the regulatory decision tree to classify the serious injury event as a reportable MDR to the FDA within 30 days. 2) Triage the remaining complaints for relevance to the over-delivery issue. 3) Draft the initial report sections, identifying the device, event, and patient impact. 4) Outline the immediate investigative actions needed from engineering.

Intermediate

Case Study/Exercise

Performance Drift Analysis and Signal Detection

Scenario

Data from your Post-Market Clinical Follow-up (PMCF) survey and complaint trend analysis shows a 15% increase in 'battery failure' complaints for a surgical stapler over 6 months, coinciding with a new supplier of battery cells. No serious injuries reported yet.

How to Execute

1) Aggregate data from complaints, returns, and PMCF surveys into a statistical process control (SPC) chart to visualize the drift. 2) Conduct a root cause investigation linking the trend to the supplier change. 3) Draft a PMS trend report with a formal recommendation to initiate a CAPA (Corrective and Preventive Action). 4) Prepare a communication plan for the regulatory affairs team to determine if an unanticipated adverse effect report is required.

Advanced

Project

Design a Proactive PMS/PMCF Strategy for a New Device Launch

Scenario

You are the Head of Post-Market Surveillance. The company is launching a novel Class III AI-powered cardiac ablation system. You must build a surveillance system that satisfies EU MDR Annex III requirements and actively monitors for algorithm performance drift in a real-world clinical setting.

How to Execute

1) Define key performance indicators (KPIs) and safety endpoints derived from the risk management file. 2) Design a multi-modal PMCF plan incorporating registry studies, targeted physician surveys, and real-time telemetry data analysis. 3) Establish automated alerts for predefined thresholds of performance deviation (e.g., algorithm accuracy drop >5%). 4) Integrate this system with the company's complaint handling and CAPA process to create a closed-loop feedback mechanism for R&D.

Tools & Frameworks

Software & Data Platforms

Complaint Management System (e.g., EtQ, Sparta TrackWise)Business Intelligence Tools (e.g., Power BI, Tableau)Statistical Software (e.g., JMP, Minitab)Electronic Regulatory Submission Platforms (e.g., Eudamed, FDA ESG)

CMS is the single source of truth for intake and trending. BI tools visualize complaint and performance data for management review. Statistical software is used for formal trend analysis and signal detection. Submission platforms are mandatory for regulatory reporting.

Mental Models & Methodologies

ISO 13485 & ISO 14971 (Risk Management)FDA's Safety Reporting Requirements (21 CFR 803)EU MDR PMS Requirements (Annex III, PSUR)Failure Mode and Effects Analysis (FMEA)Statistical Process Control (SPC)

The ISO standards and regulatory guidelines provide the mandatory framework. FMEA proactively identifies potential failure modes. SPC is the core methodology for objectively detecting performance drift versus random variation.

Interview Questions

Answer Strategy

The interviewer is testing proactive signal detection, cross-functional collaboration, and understanding of the grey area between a quality issue and a regulatory trigger. Use the framework: Detect, Assess, Decide, Act. Sample answer: 'First, I'd quantify the trend using SPC to confirm it's statistically significant, not random. I'd then convene a meeting with Human Factors Engineering and Marketing to assess the root cause-is it a training gap, a UI flaw, or changed user demographics? Based on the assessment, I'd recommend a CAPA for a software update or revised labeling, and brief Regulatory Affairs on the potential need for a supplemental report if the confusion could lead to use error affecting safety.'

Answer Strategy

This tests the ability to think like an auditor and justify decisions with data and a robust rationale. Focus on demonstrating a proactive, evidence-based approach. Sample answer: 'I would present our risk-based rationale, linking each PMCF activity (e.g., a 500-patient registry) directly to a specific residual risk or unknown from the design dossier. I'd show the inspector the plan's outputs-our interim safety report-and explain how the chosen endpoints and statistical power are sufficient to detect a clinically meaningful performance drift within the plan's timeframe. I'd emphasize that the plan is a living document reviewed annually against incoming complaint and PMS data.'